select
adapt
immun
respons
base
enorm
divers
b
cell
antigenspecif
receptor
immun
repertoir
collect
b
cell
function
divers
circulatori
system
given
time
dynam
reflect
essenc
immun
select
articl
review
recent
advanc
immun
repertoir
studi
infecti
diseas
achiev
tradit
techniqu
highthroughput
sequenc
ht
techniqu
ht
techniqu
enabl
determin
complementari
region
lymphocyt
receptor
unpreced
effici
scale
progress
methodolog
enhanc
understand
immunolog
chang
pathogen
challeng
also
provid
basi
develop
novel
diagnost
marker
immunotherapi
vaccin
figur
process
gener
divers
b
cell
repertoir
structur
heavi
chain
left
origin
rearrang
variabl
v
divers
join
j
gene
segment
recombin
occur
first
j
segment
v
segment
dj
segment
along
select
gene
segment
insert
delet
nucleotid
junction
segment
provid
initi
divers
primari
bcr
repertoir
comparison
light
chain
right
form
two
segment
v
j
make
light
chain
less
divers
encount
cognat
antigen
somat
hypermut
introduc
point
mutat
frame
region
complementari
determin
region
bcr
process
diversifi
repertoir
gener
bcr
higher
affin
hou
et
al
introduct
adapt
immun
system
compos
b
cell
form
highli
select
guard
evolv
pathogen
foundat
adapt
immun
respons
base
enorm
divers
b
cell
antigen
receptor
recogn
epitop
near
infinit
number
differ
intern
extern
antigen
profound
divers
tcr
b
cell
receptor
bcr
gener
vdj
gene
recombin
tcrbcr
locu
subsequ
somat
hypermut
classswitch
recombin
b
cell
antigen
stimul
thu
studi
immun
repertoir
portray
antigenspecif
inform
within
lymphocyt
key
understand
respons
adapt
immun
infect
despit
extens
effort
use
tradit
techniqu
analysi
immun
repertoir
high
resolut
remain
difficult
sever
sequenc
strategi
exampl
sanger
sequenc
implement
determin
cdna
segment
encod
variabl
region
immunoglobulin
tcr
howev
lowthroughput
techniqu
lack
power
provid
broad
pictur
full
immun
repertoir
past
two
decad
howev
technic
advanc
highthroughput
sequenc
ht
also
known
nextgener
sequenc
ng
along
evolv
bioinformat
statist
tool
provid
new
approach
capabl
analyz
immun
repertoir
singl
sequenc
level
method
creat
unprecedentedli
highresolut
pictur
immun
repertoir
also
provid
massiv
data
cover
lymphocyt
sampl
theori
dispens
limit
sequenc
quantiti
consid
extrem
import
role
adapt
immun
system
defend
infecti
agent
ht
great
potenti
aid
discoveri
novel
infecti
agent
also
offer
new
approach
antibodi
vaccin
develop
review
introduc
implement
ht
studi
immun
repertoir
review
associ
bioinformat
tool
requir
data
process
analysi
focu
success
technolog
facilit
explor
infectionrel
immun
repertoir
clinic
diagnosi
treatment
prevent
amaz
divers
make
immun
system
effect
system
fight
broad
scope
diseas
caus
pathogen
repertoir
gener
complex
seri
genet
event
cell
variabl
region
tcr
chain
consist
three
complementari
determin
region
cdr
four
frame
region
fr
cdr
variabl
portion
receptor
determin
antigen
specif
form
variabl
v
gene
gener
random
select
recombin
variabl
v
divers
join
j
gene
segment
heavi
chain
v
j
region
gene
segment
light
chain
figur
thu
divers
compon
receptor
bind
mhc
molecul
antigen
construct
tcr
alpha
chain
beta
chain
also
process
contribut
receptor
divers
format
revis
b
cell
lymphocyt
receptor
repertoir
highli
dynam
process
number
lymphocyt
clone
chang
dramat
depend
cell
specif
histori
antigen
exposur
encount
exogen
antigen
cell
express
receptor
capabl
bind
specif
compat
peptidemhc
pmhc
complex
expand
result
massiv
popul
antigenspecif
cell
initi
adapt
immun
respons
antigendriven
prolifer
process
cell
distinct
cell
initi
antigen
stimulu
although
two
type
cell
show
compar
protein
express
prolifer
rate
transcriptom
featur
day
noninfect
stimul
subsequ
divis
cell
differ
depend
continu
exist
selfpmhc
complex
cell
prolifer
limit
pattern
subsequ
respons
requir
persist
stimul
antigenpres
cell
cell
program
extens
expans
short
stimul
even
transfer
antigenfre
host
postantigen
stimul
respons
b
cell
complic
accompani
somat
hypermut
classswitch
recombin
offer
addit
diversif
b
cell
repertoir
somat
hypermut
process
introduc
point
mutat
produc
b
cell
higher
affin
target
antigen
higher
affin
clone
select
expand
call
affin
matur
addit
classswitch
recombin
gene
loci
encod
c
region
bcr
excis
replac
seri
new
constant
gene
segment
result
function
differ
igg
ige
iga
particip
differ
immun
mechan
pathogen
elimin
tradit
strategi
studi
immun
repertoir
prior
ht
mani
strategi
develop
explor
postinfect
immun
repertoir
immunoscop
spectratyp
use
investig
tcrbcr
repertoir
sinc
techniqu
use
one
b
cell
cell
v
j
gene
specif
primer
pair
length
determin
length
healthi
popul
show
bellshap
pattern
indic
polyclon
repertoir
howev
unusu
peak
infect
patient
impli
perturb
oligoclon
repertoir
clonal
expans
spectratyp
provid
robust
inform
complex
stabil
circul
tb
cell
repertoir
insight
immun
repertoir
infect
even
rel
easi
cheap
nucleotid
sequenc
remain
obscur
extent
heterogen
within
particular
length
assess
detail
nucleotid
sequenc
gene
segment
encod
variabl
region
determin
tradit
dna
sequenc
techniqu
sanger
sequenc
flow
cytometri
spectratyp
help
isol
tb
cell
interest
complement
weak
sanger
sequenc
quantiti
limit
singlecel
sequenc
abl
identifi
sequenc
sever
b
cell
produc
monoclon
antibodi
specif
certain
viru
contribut
greatli
analyz
genet
featur
antibodi
process
antibodi
discoveri
collect
peripher
blood
sampl
b
cell
memori
b
cell
isol
immort
produc
antibodi
accord
hai
titer
neutral
titer
determin
elisa
virusspecif
b
cell
identifi
help
narrow
b
cell
candid
sequenc
function
testbas
antibodi
discoveri
strategi
success
labori
despit
strategi
well
design
target
antibodi
search
howev
insuffici
creat
highresolut
pictur
human
immun
repertoir
highthroughput
sequenc
recent
becom
novel
power
tool
investig
immun
repertoir
depth
comprehens
highthroughput
immun
repertoir
sequenc
greater
ever
enorm
sequenc
data
diseasespecif
tcrbcr
clone
provid
great
potenti
reveal
dynam
chang
clonal
infecti
state
establish
lymphocyt
repertoir
databas
start
sampl
collect
care
select
popul
isol
interest
cell
b
cell
subgroup
due
wellacknowledg
heterogen
tcr
bcr
individu
longitudin
studi
track
dynam
alter
certain
popul
help
reduc
difficulti
data
interpret
unravel
infect
cours
classif
subgroup
cell
b
cell
eg
naiv
memori
tb
cell
cell
necessari
distinct
behavior
subgroup
consid
detail
methodolog
librari
prepar
amplif
need
care
design
sinc
affect
accuraci
ultim
sequenc
data
due
differ
v
j
gene
segment
common
primer
appli
sequenc
multiplex
pcr
capabl
amplifi
multipl
loci
simultan
howev
like
introduc
bia
nonspecif
amplif
primerdim
format
uneven
reaction
condit
precis
quantit
multiplex
pcr
may
achiev
primer
concentr
adjust
bia
filter
use
amplif
bia
among
templat
control
anoth
altern
pcr
method
pcr
provid
less
bias
pcr
librari
use
primer
bind
downstream
variabl
domain
sequenc
techniqu
evolv
continu
deeper
precis
three
preval
ht
platform
avail
today
comparison
mechan
sequenc
depth
critic
featur
platform
shown
tabl
illumina
roch
platform
commonli
use
immun
repertoir
analysi
output
platform
must
analyz
caution
notabl
platformspecif
sequenc
error
insert
delet
nucleotid
result
imperfect
interpret
homopolymer
stretch
consider
roch
platform
substitut
error
predomin
illumina
platform
overal
error
rate
illumina
platform
lowest
ion
torrent
highest
among
three
attempt
correct
sequenc
error
three
algorithm
commonli
use
includ
kmer
spectrum
multipl
sequenc
align
suffix
tree
base
pcr
sequenc
error
inevit
result
overestim
repertoir
divers
common
statist
strategi
pcr
sequenc
error
remov
elimin
low
abund
lowqual
sequenc
low
phred
score
lead
great
loss
sequenc
inform
rescu
sequenc
lowqual
sequenc
three
lowqual
nucleotid
map
core
clonotyp
deriv
highqual
sequenc
allow
mismatch
lowqual
posit
lowabund
core
clonotyp
merg
highabund
core
clonotyp
less
three
allow
mismatch
v
mismatch
mismatch
j
mismatch
gene
segment
correct
pcr
error
integr
algorithm
base
sequenc
qualiti
abund
could
effici
correct
artifici
error
avoid
inform
loss
thu
provid
reliabl
estim
repertoir
divers
uniqu
molecular
identifi
label
start
molecul
help
reduc
pcr
sequenc
error
combin
experiment
strategi
molecular
identifi
groupsbas
error
correct
migec
correct
pcr
sequenc
error
effici
qualityand
frequencybas
strategi
determin
vdj
gene
segment
rearrang
well
identif
point
mutat
often
achiev
use
immunogenet
databas
http
wwwimgtorg
despit
controversi
valid
new
vdj
gene
annot
tool
base
variou
algorithm
report
igblast
ihmmunealign
decombin
tabl
addit
mani
integr
bioinformat
tool
mitcr
lymanalyz
changeo
etc
data
process
develop
recent
tabl
provid
variou
statist
approach
divers
estim
repertoir
comparison
cluster
analysi
somat
hypermut
analysi
tabl
despit
tool
standard
bioinformat
analysi
visual
strategi
lack
remain
main
obstacl
comparison
research
differ
investig
highthroughput
sequenc
techniqu
revolution
studi
immun
repertoir
util
ht
mani
import
insight
mechan
immun
respons
gain
also
cornerston
potenti
clinic
applic
repertoir
analysi
includ
identif
diagnost
biomark
design
therapeut
antibodi
develop
new
vaccin
estim
divers
tcrbcr
repertoir
necessari
estim
theoret
size
repertoir
track
chang
clonal
popul
clinic
cours
infect
sever
differ
method
may
use
describ
divers
lymphocyt
repertoir
differ
level
vdj
recombin
divers
simpson
divers
index
nonparametr
method
decreas
overal
divers
immun
repertoir
observ
variou
antigen
exposur
includ
hiv
influenza
human
herp
viru
impli
expans
particular
tb
cell
clone
group
compar
chang
divers
tcr
beta
chain
bcr
heavi
chain
viru
infect
interestingli
result
show
divers
bcr
heavi
chain
start
increas
week
infect
tcr
beta
chain
repertoir
continu
contract
addit
divers
bcr
repertoir
less
divers
tcr
beta
chain
repertoir
convalesc
phase
correl
improv
prognos
impli
differ
respons
process
humor
cellular
immun
immun
respons
vaccin
use
ideal
model
antibodi
repertoir
research
due
conveni
draw
blood
sampl
welldefin
time
point
studi
use
vaccin
influenza
tt
reveal
dynam
chang
size
divers
antibodi
repertoir
antigen
stimul
comparison
postvaccin
respons
suggest
diverg
repertoir
properti
among
individu
differ
age
group
success
immun
individu
differ
influenza
vaccin
tiv
laiv
maximum
clonal
respons
found
occur
day
vaccin
magnitud
respons
vari
individu
despit
ident
immun
challeng
may
influenc
previou
exposur
age
concurr
immun
respons
addit
studi
b
cell
memori
achiev
repeat
sequenc
sampl
taken
individu
separ
immun
respons
antigen
vollmer
colleagu
identifi
group
bcell
clone
recal
respons
two
substanti
differ
vaccin
composit
impli
possibl
identifi
crossspecif
antibodi
use
repertoir
analysi
immun
respons
record
sequenc
data
also
use
test
role
adjuv
elicit
broadspectrum
antibodi
wiley
cowork
test
immun
respons
mice
immun
malaria
vaccin
analyz
igg
repertoir
found
tlr
agonist
use
adjuv
increas
divers
igg
variabl
region
relat
improv
abil
antibodi
recogn
broad
spectrum
epitop
studi
exemplifi
new
level
detail
assess
vaccin
respons
pioneer
ht
implic
vaccin
design
infect
patient
antigenspecif
tb
cell
repertoir
form
respons
antigen
exposur
circul
peripher
tissu
immun
repertoir
sequenc
provid
broad
inform
includ
crucial
antigenspecif
clone
potenti
halt
spread
pathogen
diagnost
marker
discoveri
use
sequenc
data
reli
antigenspecif
clone
stereotyp
featur
postinfect
repertoir
featur
assess
differ
level
gene
rearrang
ident
similar
sequenc
overlap
certain
length
influenza
vaccin
domin
clonotyp
ig
heavi
chain
vj
gene
rearrang
length
somat
mutat
posit
previous
report
influenza
antibodi
howev
studi
converg
domin
sequenc
found
one
individu
research
broader
popul
includ
nondomin
sequenc
need
success
exampl
report
ig
repertoir
relat
dengu
viru
infect
use
cross
valid
approach
stereotyp
sequenc
length
high
preval
acut
dengu
sampl
found
specif
acut
dengu
infect
absent
low
preval
healthi
postconvalesc
popul
identif
pathogenspecif
sequenc
also
help
differenti
diagnosi
infecti
noninfecti
diseas
accord
dziubianau
et
al
compar
pbmcsderiv
cell
clonotyp
specif
given
viru
cell
differ
origin
allograftderiv
urinederiv
lymphocyt
provid
new
methodolog
differenti
diagnosi
two
posttranspl
complic
bkvassoci
nephropathi
acut
cellular
reject
show
glimps
applic
cell
sequenc
diagnosi
addit
recent
studi
search
sequenc
data
amino
acid
motif
report
specif
particular
pathogen
succeed
identifi
sequenc
ident
similar
motif
postvaccin
volunt
accord
result
interestingli
low
frequenc
sequenc
possess
probabl
becom
promis
biomark
instead
domin
one
howev
immun
respons
show
dramat
differ
sequenc
respond
pathogen
across
individu
age
group
intrins
diverg
individu
major
obstacl
find
public
sequenc
optim
biomark
nevertheless
hold
promis
applic
ht
data
differenti
diagnosi
provid
larg
number
candid
sequenc
biomark
investig
instead
use
singl
biomark
psa
afp
diagnosi
combin
panel
select
sequenc
may
establish
pathogenspecif
sequenc
librari
diagnosi
hold
potenti
unpreced
sensit
specif
recombin
monoclon
antibodi
great
potenti
treatment
specif
infect
recent
year
sever
strategi
includ
phage
display
librari
singl
b
cell
express
b
cell
immort
use
discov
antibodi
specif
antigen
ht
antibodi
repertoir
combin
subsequ
bioinformat
tool
tradit
screen
tool
facilit
identif
antigenspecif
sequenc
methodolog
predict
antigen
specif
complet
analysi
bcr
sequenc
possibl
yet
albeit
consider
potenti
immun
repertoir
studi
nevertheless
mani
effort
made
mine
ht
data
function
antibodi
rel
direct
method
identifi
sequenc
base
similar
amino
acid
sequenc
previous
report
antibodi
research
success
found
sequenc
high
ident
broadli
neutral
antibodi
strainspecif
antibodi
establish
antibodi
repertoir
patient
influenza
infect
vaccin
sequenc
proven
neutral
activ
valid
potenti
deep
sequencingbas
antibodi
identif
success
work
also
suggest
possibl
monoclon
antibodi
synthesi
without
cell
clone
treatment
furthermor
anoth
method
use
frequenc
rank
heavi
chain
light
chain
sequenc
predict
function
antibodi
sequenc
report
success
mous
model
excit
work
kwong
cowork
demonstr
feasibl
identifi
neutral
activ
clone
bioinformat
analysi
hiv
patient
establish
sever
step
interrog
variant
known
neutral
antibodi
class
hivinfect
patient
without
previou
knowledg
patient
antibodi
belong
famili
first
heavi
light
chain
sequenc
deriv
germlin
ighv
iglv
gene
templat
antibodi
isol
new
donor
sequenc
compar
germlin
gene
diverg
templat
antibodi
sequenc
ident
gener
contour
plot
call
divergenceident
plot
sequenc
segreg
cluster
plot
high
diverg
high
ident
sequenc
select
candid
neutral
antibodi
process
call
gridbas
strategi
germlin
sequenc
candid
sequenc
templat
antibodi
sequenc
class
merg
build
phylogenet
tree
root
templat
sequenc
call
crossdonor
analysi
heavi
chain
sequenc
new
donor
cluster
subtre
templat
sequenc
express
templat
light
chain
gener
antibodi
sequenc
neutral
activ
outstand
effici
method
also
demonstr
compar
sequencebas
strategi
prevalencebas
strategi
lu
et
al
also
valid
phylogenet
method
identifi
function
antistaphylococcu
aureu
antibodi
strategi
start
previous
report
antibodi
sequenc
howev
antibodi
sequenc
alway
avail
especi
poorli
character
viral
infect
pair
heavi
light
chain
integr
antibodi
anoth
challeng
htsbase
immun
repertoir
analysi
case
research
focu
heavi
chain
caus
critic
loss
antibodi
integr
lead
problem
follow
synthesi
artifici
monoclon
antibodi
two
strategi
report
correctli
pair
heavi
chain
light
chain
sequenc
base
frequenc
evolut
model
reddi
colleagu
pioneer
pair
base
frequenc
rank
use
plasma
cell
isol
bone
marrow
immun
mice
match
two
chain
similar
rank
order
monoclon
antibodi
express
way
show
antigen
specif
due
linkag
heavi
chain
light
chain
integr
protein
evolut
undergo
enzymat
mutat
process
evolv
togeth
bind
antigen
high
affin
base
theoret
foundat
phylogen
analysi
use
anoth
method
compar
evolutionari
topographi
heavi
chain
light
chain
bioinformat
identif
transcript
relat
known
hiv
neutral
antibodi
reconstitut
novel
antibodi
consist
phylogenet
match
chain
show
similar
neutral
function
less
autoreact
compar
mismatch
one
sever
group
recent
achiev
advanc
technolog
pair
sequenc
antibodi
singlecel
pcr
util
creat
twodimension
barcod
primer
matrix
link
two
chain
bcr
use
techniqu
buss
cowork
analyz
pair
sequenc
b
cell
one
experi
accomplish
subsequ
antibodi
gene
clone
express
time
turchaninova
cowork
perform
pioneer
research
emulsionbas
technolog
sequenc
antibodi
repertoir
pair
chain
use
waterinoil
emuls
cellbas
overlap
expans
rtpcr
although
yield
rel
low
yield
anoth
highthroughput
pair
sequenc
method
dekoski
et
al
use
micro
well
plate
isol
b
cell
magnet
bead
captur
mrna
recent
dekoski
group
combin
improv
previou
techniqu
develop
costeffect
effici
methodolog
establish
precis
pair
repertoir
predict
cell
specif
base
tcr
heterodim
sequenc
difficult
antibodi
highli
variabl
natur
compon
tcrpeptidemhc
complex
due
challeng
pose
highli
variabl
loop
tcr
complex
predict
proteinprotein
interact
experiment
function
test
mine
antigenspecif
cell
might
fruit
approach
recent
advanc
htsbase
antibodi
sequenc
may
provid
biggest
benefit
field
vaccin
develop
year
effort
elicit
protect
immun
respons
hiv
immun
success
acut
viral
infect
highaffin
neutral
antibodi
develop
week
howev
gener
effect
broadli
neutral
antibodi
chronic
infect
hiv
take
significantli
longer
time
furthermor
neutral
power
antibodi
often
variabl
due
impair
host
immun
function
unusu
featur
env
coevolut
viru
respons
host
antibodi
respons
deep
sequenc
analysi
identifi
rare
variant
known
hivneutr
antibodi
elucid
ontogeni
neutral
antibodi
find
cast
light
antibodi
guid
vaccin
develop
follow
studi
htsbase
phylogenet
strategi
greatli
facilit
studi
coevolut
neutral
antibodi
viru
mutant
combin
longterm
followup
studi
result
illustr
mutat
site
allow
viru
escap
neutral
antibodi
viru
help
secondari
neutral
antibodi
becom
sensit
neutral
antibodi
studi
suggest
promis
pathway
elicit
broadli
neutral
antibodi
sequenti
immun
select
immunogen
furthermor
structur
studi
neutral
antibodi
famili
provid
candid
futur
vaccin
design
highthroughput
sequenc
breakthrough
technolog
studi
immun
repertoir
alreadi
profound
effect
knowledg
immun
system
physiolog
health
diseas
particular
ht
transform
understand
immun
repertoir
format
infect
malign
autoimmun
advanc
file
research
reli
progress
similar
laboratori
techniqu
collect
precis
sequenc
data
anticip
consist
improv
sequenc
techniqu
error
correct
strategi
increas
number
research
shown
interest
area
recent
year
provid
vast
quantiti
data
could
provid
answer
import
exist
question
data
repositori
effect
util
establish
public
databas
collect
deep
sequenc
data
collect
collabor
facilit
inform
exchang
investig
varieti
repertoir
across
gender
age
race
healthi
state
addit
develop
standard
bioinformat
tool
indispens
har
ht
output
although
expect
potenti
immun
repertoir
studi
clinic
use
enorm
work
remain
done
incorpor
observ
dynam
chang
sequenc
signatur
clinic
featur
outcom
question
remain
sever
certain
infect
relat
alter
immun
repertoir
respons
variou
manifest
sequenc
predict
abund
protect
immunoglobulin
cell
given
sequenc
librari
term
therapeut
discoveri
identif
product
function
antibodi
cell
promot
develop
passiv
immun
therapi
vaccin
tradit
recent
report
largescal
screen
strategi
may
contribut
greatli
process
advanc
ht
immun
repertoir
health
diseas
provid
comprehens
view
adapt
immun
respons
near
futur
open
door
rational
immunotherapi
infect
dh
involv
studi
design
wrote
first
draft
manuscript
conduct
literatur
search
review
abstract
perform
analysi
contribut
final
draft
cc
sc
involv
studi
design
review
abstract
es
revis
manuscript
ys
design
supervis
studi
revis
final
draft
contribut
analysi
author
read
approv
final
manuscript
